Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisha Lateef

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Lupus Science & Medicine|November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort studyRangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology (Oxford, England)|December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort studyRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort studyJiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology|March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus ErythematosusVera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Lupus Science & Medicine|February 12, 2025
Time trends of variability in disease activity in systemic lupus erythematosusNing Li, Alberta Hoi, Shue-Fen Luo, et al.
Rheumatology (Oxford, England)|May 11, 2026
Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort studyLuigi Zolio, Yanjie Hao, Rangi Kandane-Rathnayake, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|November 18, 2025
Predictors of damage accrual by organ domain in systemic lupus erythematosusRangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Lupus Science & Medicine|November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort studyRangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology (Oxford, England)|December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort studyRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort studyJiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology|March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus ErythematosusVera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Lupus Science & Medicine|February 12, 2025
Time trends of variability in disease activity in systemic lupus erythematosusNing Li, Alberta Hoi, Shue-Fen Luo, et al.
Rheumatology (Oxford, England)|May 11, 2026
Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort studyLuigi Zolio, Yanjie Hao, Rangi Kandane-Rathnayake, et al.
Pageof 6